전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
in vitro and animal data suggest that bromelain can also promote fibrinolysis.
in vitro ja loomkatsete andmed lubavad oletada, et bromelaiin võib soodustada ka fibrinolüüsi.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
the fibrin clot is metabolised in the same way as endogenous fibrin by fibrinolysis and phagocytosis.
fibriinhüüve lagundatakse fibrinolüüsi ja fagotsütoosi teel samal viisil kui endogeenne fibriingi.
마지막 업데이트: 2012-04-11
사용 빈도: 2
품질:
fibrin sealants/haemostatics are metabolised in the same way as endogenous fibrin by fibrinolysis and phagocytosis.
fibriinkoeliimid/hemostaatikumid metaboliseeruvad samuti kui endogeenne fibriin fibrinolüüsi ja fagotsütoosi kaudu.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
fibrin sealants/haemostatics are metabolised in the same way as endogenous fibrin, by fibrinolysis and phagocytosis.
fibriinkoeliimid ja/või hemostaatikumid metaboliseeruvad fibrinolüüsi ja fagotsütoosi teel samamoodi kui endogeenne fibriin.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
in vitro interaction studies were performed with a commercially available fibrin glue containing aprotinin (a fibrinolysis inhibitor of bovine origin).
in vitro koostoimeuuringud viidi läbi kaubandusliku aprotiniini (veisepäritoluga fibrinolüüsiinhibiitor) sisaldava fibriinliimiga.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
the active transglutaminase cross-links fibrin and other proteins resulting in increased mechanical strength and resistance to fibrinolysis of the fibrin clot and contributes to enhanced platelet and clot adhesion to the injured tissue.
aktiivne fxiii a-alaühik (transglutaminaas ) seob ristühenduse abil fibriini ja teised valgud, mille tagajärjel fibriinikämbu mehaaniline tugevus suureneb ja see muutub fibrinolüüsi suhtes vastupidavamaks ning soodustab vereliistakute ja trombi kleepumist kahjustatud koele.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
however, the concomitant use of another type of fibrin glue with a synthetic fibrinolysis inhibitor (tranexamic acid) in the pivotal clinical trial did not reveal any safety signal.
samas teist liiki, sünteetilise fibrinolüüsiinhibiitoriga (traneksaamhape) fibriinliimi kasutamisel esmases kliinilises uuringus ohutusprobleeme ei ilmnenud.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
since the use of factor ix complex concentrates has historically been associated with the development of thromboembolic complications, the risk being higher in low purity preparations, the use of factor ix-containing products may be potentially hazardous in patients with signs of fibrinolysis and in patients with disseminated intravascular coagulation (dic).
et ix faktori kompleksi kontsentraatide kasutamist on ajalooliselt seostatud trombembooliliste komplikatsioonide tekkimisega, mille risk on olnud suurem madalama puhtusastmega preparaatide puhul, võib ix faktorit sisaldavate preparaatide kasutamine olla potentsiaalselt ohtlik nendele patsientidele, kellel esinevad fibrinolüüsi nähud ja dissemineeritud intravaskulaarne koagulatsioon (dik).
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질: